Late complications after percutaneous tracheostomy and oral intubation: Evaluation of 1,628 procedures

Storm, Benjamin; Dybwik, Knut

doi:10.1002/lary.25766

Cited by 9 publications

(10 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, for the majority of patients, health care teams should seek to capitalize on the intersection of the risk of contamination/infection and decreasing viral load in the upper and lower airways over time with the risks of prolonged intubation (ie, tracheal stenosis, weaning issues, pulmonary toilet, etc.). Although the overall risk of tracheal stenosis secondary to prolonged intubation depends on a variety of factors, reported rates of severe, symptomatic stenosis are generally in the 1% to 2% range when modern low‐pressure cuffs are utilized 28‐32 . Therefore, in light of the relatively low risk of clinically relevant stenosis, and despite the traditional 10‐day cutoff for increased stenosis risk used by many practitioners in the general population, when dealing with a SARS‐CoV‐2 patient, the risk for symptomatic or severe tracheal stenosis is acceptable in light of the significant risks of tracheostomy in the acute phase of the infection during periods of the highest viral loads.…”

Section: Recommendationsmentioning

confidence: 99%

Tracheostomy during SARS‐CoV‐2 pandemic: Recommendations from the New York Head and Neck Society

et al. 2020

View full text Add to dashboard Cite

The rapid spread of SARS-CoV-2 in 2019 and 2020 has resulted in a worldwide pandemic characterized by severe pulmonary inflammation, effusions, and rapid respiratory compromise. The result of this pandemic is a large and increasing number of patients requiring endotracheal intubation and prolonged ventilator support. The rapid rise in endotracheal intubations coupled with prolonged ventilation requirements will certainly lead to an increase in tracheostomy procedures in the coming weeks and months. Performing tracheostomy in the setting of active SARS-CoV-2, when necessary, poses a unique situation, with unique risks and benefits for both the patient and the health care providers. The New York Head and Neck Society has collaborated on this document to provide guidance on the performance of tracheostomies during the SARS-CoV-2 pandemic.

show abstract

Section: Recommendationsmentioning

confidence: 99%

Tracheostomy during SARS‐CoV‐2 pandemic: Recommendations from the New York Head and Neck Society

et al. 2020

View full text Add to dashboard Cite

show abstract

“…When performed regularly, percutaneous tracheotomy is now a safe procedure with a low short‐term complication rate . When performed by a small dedicated number of persons, we have previously shown that percutaneous tracheotomy is a safe procedure also with very low numbers of low long‐term complications . Although our new method for single left lobe recruitment could seem complex at first, it was not complicated to perform.…”

Section: Discussionmentioning

confidence: 93%

“…3 When performed by a small dedicated number of persons, we have previously shown that percutaneous tracheotomy is a safe procedure also with very low numbers of low long-term complications. 4 Although our new method for single left lobe recruitment could seem complex at first, it was not complicated to perform. Once percutaneous tracheotomy is considered safe, also the rest of our procedure is safe.…”

Section: T a B L E 1 ( Continued)mentioning

confidence: 99%

A successful new method for single left lobe recruitment

Dybwik

2018

Clinical Case Reports

Self Cite

View full text Add to dashboard Cite

Key Clinical MessageAny gas will flow down the path of least resistance and highest compliance. This is a problem in the treatment of severe unilateral lung disease in the intensive care unit (ICU). Deep sedation interferes with the diaphragm's ability to distribute air into the lower lung. Spontaneous breathing in a conscious patient, in combination with mechanical ventilation via an endotracheal tube inserted into the left main stem bronchus, can recruit collapsed alveoli.

show abstract

“…In addition, the number of evidence-based treatments for tobacco dependence has increased. The initial report by the National Lung Screening Trial, on the efficacy of low dose CT screening in reducing lung cancer mortality, also emphasized the importance of a healthcare team to provide a “teachable moment” of tobacco cessation benefits [29–31]. Expanded Medicare reimbursement for tobacco cessation counselling to include all patients identified with tobacco abuse occurred in 2010, which also coincided with increased CMS reimbursement [32].…”

Section: Discussionmentioning

confidence: 99%

Trends in tobacco use and tobacco cessation counselling codes among Medicare beneficiaries, 2001–2014

Nishi

Zhou

Kuo

et al. 2019

BMC Health Serv Res

View full text Add to dashboard Cite

Background Analysis of Medicare data is often used to determine epidemiology, healthcare utilization and effectiveness of disease treatments. We were interested in whether Medicare data could be used to estimate prevalence of tobacco use. Currently, data regarding tobacco use is derived from Behavioral Risk Factor Surveillance System (BRFSS) survey data. We compare administrative claims data for tobacco diagnosis among Medicare beneficiaries to survey (BRFSS) estimates of tobacco use from 2001 to 2014. Methods Retrospective cross-sectional study comparing tobacco diagnoses using International Classification of Disease, Ninth Revision (ICD-9) codes for tobacco use in Medicare data to BRFSS data from 2001 to 2014 in adults age ≥ 65 years. Beneficiary data included age, gender, race, socioeconomic status, and comorbidities. Tobacco cessation counselling was also examined using Healthcare Common Procedure Coding System codes. Results The prevalence of Medicare enrollees aged ≥65 years who had a diagnosis of current tobacco use increased from 2.01% in 2001 to 4.8% in 2014, while the estimates of current tobacco use from BRFSS decreased somewhat (10.03% in 2001 vs. 8.77% in 2014). However, current tobacco use based on Medicare data remained well below the estimates from BRFSS. Use of tobacco cessation counselling increased over the study period with largest increases after 2010. Conclusions The use of tobacco-related diagnosis codes increased from 2001 to 2014 in Medicare but still substantially underestimated the prevalence of tobacco use compared to BRFSS data.

show abstract

Late complications after percutaneous tracheostomy and oral intubation: Evaluation of 1,628 procedures

Abstract: 4 Laryngoscope, 126:1077-1082, 2016.

Cited by 9 publications

References 7 publications

Tracheostomy during SARS‐CoV‐2 pandemic: Recommendations from the New York Head and Neck Society

Tracheostomy during SARS‐CoV‐2 pandemic: Recommendations from the New York Head and Neck Society

A successful new method for single left lobe recruitment

Trends in tobacco use and tobacco cessation counselling codes among Medicare beneficiaries, 2001–2014

Contact Info

Product

Resources

About